DE202010011556U1 - Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics - Google Patents

Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics Download PDF

Info

Publication number
DE202010011556U1
DE202010011556U1 DE202010011556U DE202010011556U DE202010011556U1 DE 202010011556 U1 DE202010011556 U1 DE 202010011556U1 DE 202010011556 U DE202010011556 U DE 202010011556U DE 202010011556 U DE202010011556 U DE 202010011556U DE 202010011556 U1 DE202010011556 U1 DE 202010011556U1
Authority
DE
Germany
Prior art keywords
preparations
oil
carvacrol
cineole
disinfectants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202010011556U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oktem Alper Drmed
Original Assignee
Oktem Alper Drmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oktem Alper Drmed filed Critical Oktem Alper Drmed
Priority to DE202010011556U priority Critical patent/DE202010011556U1/en
Publication of DE202010011556U1 publication Critical patent/DE202010011556U1/en
Priority to TR2011/02242A priority patent/TR201102242A2/en
Priority to DE202011102567U priority patent/DE202011102567U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

Zubereitungen in Form von Cremen, Cremeschäume, Salben, Balsams und Gele (Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel, Wundtherapeutika)
dadurch gekennzeichnet,
dass sie Carvacrol, 1,8-Cineol bzw. das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und das Mazerat von Johanneskraut (Hypericum perforatum) z. B. in Olivenöl bzw. Hyperforin enthalten,
Zu diesem Zweck sollte der Gehalt an Carvacrol, 1,8-Cineol bzw. das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und das Mazerat von Johanneskraut (Hypericum perforatum) in Olivenöl bzw. Hyperforin jeweils nicht unter 1% bzw. nicht über 90% liegen.Preparations in the form of creams, creams, ointments, balms and gels (pharmaceuticals, disinfectants, care and hygiene preparations, wound therapeutics)
characterized,
that they carvacrol, 1,8-cineole or the oil of the three-lobed sage (Salvia trilobae aetheroleum) and the maceration of St. John's wort (Hypericum perforatum) z. B. contained in olive oil or hyperforin,
For this purpose, the content of carvacrol, 1,8-cineole or the oil of the three-lobed sage (Salvia trilobae aetheroleum) and the St. John's wort macerate (Hypericum perforatum) in olive oil or hyperforin should not be less than 1% and not more than 90% % lie.

Description

Die Erfindung betrifft Zubereitungen (Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel, Wundtherapeutika) mit Carvacrol (Hauptkomponenten vom Oreganoöl-Origani aetheroleum), 1,8-Cineol oder das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und das Mazerat von Johanneskraut (Hypericum perforatum) z. B. in Olivenöl bzw. dessen Hauptkomponenten Hyperforin enthalten.The The invention relates to preparations (pharmaceuticals, disinfectants, Care and hygiene products, wound therapeutics) with carvacrol (main components from oregano oil-Origani aetheroleum), 1,8-cineole or the oil the three-lobed sage (Salvia trilobae aetheroleum) and the macerate of St. John's wort (Hypericum perforatum) z. B. in olive oil or whose main components contain hyperforin.

Durch den Stand der Technik ist es bekannt:
Die antimikrobielle Wirkung des Oregano-Öls mit dem Hauptkomponenten Carvacrol gegen mehrere Bakterien und Pilze, u. a. Staphylokokken sowie MRSA, E. coli, Pseudomonas aeruginosa, Streptococcus pneumoniae, Corynebacterium xerosis, A. niger, Candida albicans ist bekannt.

  • (Gebrauchsmuster Nr. 20 2004 012 410.6 vom Anmelder.
  • Gebrauchsmuster Nr. 20 2004 01.5 396.3 vom Anmelder.
  • Gebrauchsmuster Nr. 20 2007 003 020.7 vom Anmelder.
  • Gebrauchsmuster Nr. 20 2007 015 735.5 vom Anmelder.
  • Gebrauchsmuster Nr. 20 2008 009 382.1 vom Anmelder.
  • „Oregano”, edited by Spiridon E. Kintzios, Kapitel 4, Taylor & Francis.
  • D. Horne et al.: Antimicrobial Effects of essential Oils an Streptococcus pneumoniae, J. Essent. Oil Res., 13 (September/October 2001): 387–392
  • Lacoste et al: Antiseptic properties of Lippia sidoides Cham. Application to the cuteneous microflora. Ann Pharm Fr 1996; 54 (5): 228–30”
  • Manohar et al.: Antifungal activities of origanum oil against Candida albicans. Molecular and Cellular Biochemistry 2001; Vol. 228 (1/2): p: 111–117 )
It is known by the prior art:
The antimicrobial effect of the oregano oil with the main component carvacrol against several bacteria and fungi, including staphylococci and MRSA, E. coli, Pseudomonas aeruginosa, Streptococcus pneumoniae, Corynebacterium xerosis, A. niger, Candida albicans is known.
  • (Utility model no. 20 2004 012 410.6 from the applicant.
  • Utility Model No. 20 2004 01.5 396.3 by the applicant.
  • Utility Model No. 20 2007 003 020.7 by the applicant.
  • Utility Model No. 20 2007 015 735.5 by the applicant.
  • Utility model no. 20 2008 009 382.1 by the applicant.
  • "Oregano", edited by Spiridon E. Kintzios, Chapter 4, Taylor & Francis.
  • Horne, et al .: Antimicrobial Effects of Essential Oils to Streptococcus pneumoniae, J. Essent. Oil Res., 13 (September / October 2001): 387-392
  • Lacoste et al: Antiseptic properties of Lippia sidoides Cham. Application to the cuteneous microflora. Ann Pharm Fr 1996; 54 (5): 228-30 "
  • Manohar et al .: Antifungal activities of organic oil against Candida albicans. Molecular and Cellular Biochemistry 2001; Vol. 228 (1/2): p: 111-117 )

Die antibakterielle Wirkung vom Oreganoöls geht vor allem aus dem Hauptkomponenten Carvacrol aus. ( Nostro A. et al.: Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letters 2004; 230: 191–195 . Ultee et al.: Mechanismus of Action of Carvacrol an the Food-Borne Pathogen Bacillus cereus. Appl. Environ. Microbiol 1999; 65 (10): 4606–4610 )The antibacterial effect of oregano oil is mainly due to the main component carvacrol. ( Nostro A. et al .: Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letters 2004; 230: 191-195 , Ultee et al .: Mechanism of Action of Carvacrol on the Food Borne Pathogen Bacillus cereus. Appl. Environ. Microbiol 1999; 65 (10): 4606-4610 )

Das Mazerat des Hypericum perforatum fördert die Wundheilung. Ferner besitzt Hypericum perforatum antibakterielle und antivirale Aktivität. ( WHO monographs an Selected Medicinal Plants, Vol. 2, Geneva: World Health Organisation; 1999 ).The macerate of Hypericum perforatum promotes wound healing. Furthermore, Hypericum perforatum has antibacterial and antiviral activity. ( WHO monographs to Selected Medicinal Plants, Vol. 2, Geneva: World Health Organization; 1999 ).

Der im Schutzanspruch 1 angegebenen Erfindung liegt das Problem zugrunde, dass bei Verwendung vom Oreganoöl (Origani aetheroleum) wegen der (häufig) darin enthaltenen Linalool und Limonene eine Allergiegefahr besteht. (Gebrauchsmuster Nr. 20 2008 009 382.1 vom Anmelder).Of the in claim 1 protection invention is based on the problem when using oregano oil (Origani aetheroleum) because of the (often) contained linalool and limonene an allergy danger exists. (Utility Model No. 20 2008 009 382.1 from the applicant).

Dieses Problem wird mit den im Schutzanspruch 1 aufgeführten Merkmalen gelöst. Anstelle vom Oreganoöl wird dessen Hauptkomponent Carvacrol verwendet und anstelle von Salvia trilobae aetheroleum dessen Hauptkomponent 1,8-Cineol bevorzugt. Ferner kann die Zubereitung durch die Verwendung von Hyperforin – anstelle vom Mazerat des Johanneskrauts – übersichtlicher gemacht werden.This Problem is with the features listed in the protection claim 1 solved. Instead of oregano oil is its main component Carvacrol is used and instead of Salvia trilobae aetheroleum whose main component prefers 1,8-cineole. Furthermore, the preparation through the use of hyperforin - instead of macerate of the Johanneskrauts - be made clearer.

Zu diesem Zweck sollte der Gehalt an Carvacrol, 1,8-Cineol bzw. an das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und an das Mazerat von Johanneskraut (Hypericum perforatum) in Olivenöl bzw. Hyperforin jeweils nicht unter 1% bzw. nicht über 90% liegen.To For this purpose, the content of carvacrol, 1,8-cineole or on the oil of the three-lobed sage (Salvia trilobae aetheroleum) and to the maceration of St. John's wort (Hypericum perforatum) in olive oil or hyperforin in each case not less than 1% or not over 90% lie.

Ausführungsbeispiele:EXAMPLES

  • Zubereitung mit Carvacrol – 1,8-Cineol – und das Mazerat von Johanneskraut z. B. in Olivenöl Carvacrol 12,5% 1,8-Cineol 7,5% Das Mazerat von Johanneskraut in Olivenöl 10% Olivenöl 10% Shea Butter 55% Kieselsäure 5%Preparation with carvacrol - 1,8-cineole - and the maceration of St. John's wort z. B. in olive oil carvacrol 12.5% 1,8-cineole 7.5% The maceration of St. John's wort in Olive oil 10% Olive oil 10% Shea butter 55% Silica 5%

  • Mit Carvacrol – Dreilappiger Salbei – und das Mazerat von Johanneskraut z. B. in Olivenöl Carvacrol 12,5% Das Öl der Salvia Triloba (Dreilappiger Salbei) 7,5% Das Mazerat von Johanneskraut in Olivenöl 10% Olivenöl 10% Shea Butter 55% Kieselsäure 5%With Carvacrol - Dreilappiger Sage - and the maceration of St. John's wort z. B. in olive oil carvacrol 12.5% The oil of Salvia triloba (three-lobed sage) 7.5% The maceration of St. John's wort in olive oil 10% olive oil 10% Shea Butter 55% Silica 5%

  • Zubereitung mit Carvacrol – 1,8-Cineol – Hyperforin Carvacrol 12,5% 1,8-Cineol 7,5% Hyperforin 10% Olivenöl 10% Shea Butter 55% Kieselsäure 5%Preparation with carvacrol - 1,8-cineole - hyperforin carvacrol 12.5% 1,8-cineole 7.5% Hyperforin 10% olive oil 10% Shea Butter 55% Silica 5%

ZITATE ENTHALTEN IN DER BESCHREIBUNGQUOTES INCLUDE IN THE DESCRIPTION

Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Zitierte Nicht-PatentliteraturCited non-patent literature

  • - „Oregano”, edited by Spiridon E. Kintzios, Kapitel 4, Taylor & Francis. [0002] - "Oregano", edited by Spiridon E. Kintzios, Chapter 4, Taylor & Francis. [0002]
  • - D. Horne et al.: Antimicrobial Effects of essential Oils an Streptococcus pneumoniae, J. Essent. Oil Res., 13 (September/October 2001): 387–392 [0002] D. Horne et al .: Antimicrobial Effects of Essential Oils to Streptococcus pneumoniae, J. Essent. Oil Res., 13 (September / October 2001): 387-392 [0002]
  • - Lacoste et al: Antiseptic properties of Lippia sidoides Cham. Application to the cuteneous microflora. Ann Pharm Fr 1996; 54 (5): 228–30” [0002] Lacoste et al .: Antiseptic properties of Lippia sidoides Cham. Application to the cuteneous microflora. Ann Pharm Fr 1996; 54 (5): 228-30 " [0002]
  • - Manohar et al.: Antifungal activities of origanum oil against Candida albicans. Molecular and Cellular Biochemistry 2001; Vol. 228 (1/2): p: 111–117 [0002] - Manohar et al .: Antifungal activities of organic oil against Candida albicans. Molecular and Cellular Biochemistry 2001; Vol. 228 (1/2): p: 111-117 [0002]
  • - Nostro A. et al.: Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letters 2004; 230: 191–195 [0003] - Nostro A. et al .: Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letters 2004; 230: 191-195 [0003]
  • - Ultee et al.: Mechanismus of Action of Carvacrol an the Food-Borne Pathogen Bacillus cereus. Appl. Environ. Microbiol 1999; 65 (10): 4606–4610 [0003] - Ultee et al .: Mechanism of Action of Carvacrol on the Food Borne Pathogen Bacillus cereus. Appl. Environ. Microbiol 1999; 65 (10): 4606-4610 [0003]
  • - WHO monographs an Selected Medicinal Plants, Vol. 2, Geneva: World Health Organisation; 1999 [0004] - WHO monographs to Selected Medicinal Plants, Vol. 2, Geneva: World Health Organization; 1999 [0004]

Claims (1)

Zubereitungen in Form von Cremen, Cremeschäume, Salben, Balsams und Gele (Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel, Wundtherapeutika) dadurch gekennzeichnet, dass sie Carvacrol, 1,8-Cineol bzw. das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und das Mazerat von Johanneskraut (Hypericum perforatum) z. B. in Olivenöl bzw. Hyperforin enthalten, Zu diesem Zweck sollte der Gehalt an Carvacrol, 1,8-Cineol bzw. das Öl der dreilappigen Salbei (Salvia trilobae aetheroleum) und das Mazerat von Johanneskraut (Hypericum perforatum) in Olivenöl bzw. Hyperforin jeweils nicht unter 1% bzw. nicht über 90% liegen.Preparations in the form of creams, creams, ointments, balms and gels (pharmaceuticals, disinfectants, care and sanitary preparations, wound therapeutics), characterized in that they contain carvacrol, 1,8-cineole or the oil of three-lobed sage (Salvia trilobae aetheroleum) and the maceration of St. John's wort (Hypericum perforatum) z. For this purpose, the content of carvacrol, 1,8-cineole or the oil of the three-lobed sage (Salvia trilobae aetheroleum) and the maceration of St. John's wort (Hypericum perforatum) in olive oil or hyperforin respectively not less than 1% or not more than 90%.
DE202010011556U 2010-08-19 2010-08-19 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics Expired - Lifetime DE202010011556U1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE202010011556U DE202010011556U1 (en) 2010-08-19 2010-08-19 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics
TR2011/02242A TR201102242A2 (en) 2010-08-19 2011-03-09 Partial or total combination of oregano, sage and centaury oil and their main components.
DE202011102567U DE202011102567U1 (en) 2010-08-19 2011-06-29 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202010011556U DE202010011556U1 (en) 2010-08-19 2010-08-19 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Publications (1)

Publication Number Publication Date
DE202010011556U1 true DE202010011556U1 (en) 2010-10-21

Family

ID=42994202

Family Applications (2)

Application Number Title Priority Date Filing Date
DE202010011556U Expired - Lifetime DE202010011556U1 (en) 2010-08-19 2010-08-19 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics
DE202011102567U Expired - Lifetime DE202011102567U1 (en) 2010-08-19 2011-06-29 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE202011102567U Expired - Lifetime DE202011102567U1 (en) 2010-08-19 2011-06-29 Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Country Status (2)

Country Link
DE (2) DE202010011556U1 (en)
TR (1) TR201102242A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011102567U1 (en) 2010-08-19 2011-11-10 Alper Öktem Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202004012410U1 (en) 2004-08-07 2004-12-23 Öktem, Alper Hardened ethereal oils, useful for medicinal, aroma therapy, cosmetic and pharmaceutical purposes, contain oil of oregano, trilobate sage and/or bay leaves diluted with at least equal amount of lanolin and/or shea butter
DE202004015396U1 (en) 2004-10-06 2005-02-17 Öktem, Alper Mixture of oregano oil and lanolin, useful for control of methicillin-resistant Staphylococcus aureus on skin and in the nose
DE202007003020U1 (en) 2007-03-01 2007-06-21 Öktem, Alper, Dr.med. Preparation, useful e.g. in disinfecting agent and wound therapy, comprises fundamental oregano oil, Salvia triloba, coriander oil, geranium oil, cinnamon oil and/or lemon grass oil
DE202007015735U1 (en) 2007-11-12 2008-01-03 Öktem, Alper, Dr.med. Preparations as pharmaceuticals, disinfectants, care and hygiene preparations or wound therapeutics
DE202008009382U1 (en) 2008-07-11 2008-09-11 Öktem, Alper, Dr.med. Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics
DE202010011556U1 (en) 2010-08-19 2010-10-21 Öktem, Alper, Dr.med. Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Oregano", edited by Spiridon E. Kintzios, Kapitel 4, Taylor & Francis.
D. Horne et al.: Antimicrobial Effects of essential Oils an Streptococcus pneumoniae, J. Essent. Oil Res., 13 (September/October 2001): 387-392
Lacoste et al: Antiseptic properties of Lippia sidoides Cham. Application to the cuteneous microflora. Ann Pharm Fr 1996; 54 (5): 228-30"
Manohar et al.: Antifungal activities of origanum oil against Candida albicans. Molecular and Cellular Biochemistry 2001; Vol. 228 (1/2): p: 111-117
Nostro A. et al.: Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letters 2004; 230: 191-195
Ultee et al.: Mechanismus of Action of Carvacrol an the Food-Borne Pathogen Bacillus cereus. Appl. Environ. Microbiol 1999; 65 (10): 4606-4610
WHO monographs an Selected Medicinal Plants, Vol. 2, Geneva: World Health Organisation; 1999

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011102567U1 (en) 2010-08-19 2011-11-10 Alper Öktem Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics

Also Published As

Publication number Publication date
DE202011102567U1 (en) 2011-11-10
TR201102242A2 (en) 2012-05-21

Similar Documents

Publication Publication Date Title
Chaudhari et al. Antimicrobial activity of commercially available essential oils against Streptococcus mutans
Yanakiev Effects of cinnamon (Cinnamomum spp.) in dentistry: A review
Tresch et al. Medicinal plants as therapeutic options for topical treatment in canine dermatology? A systematic review
WO2015138479A1 (en) Botanical antimicrobial compositions
Wongsariya et al. Synergistic interaction and mode of action of Citrus hystrix essential oil against bacteria causing periodontal diseases
dos Santos Cardoso et al. Efficacy of medicinal plant extracts as dental and periodontal antibiofilm agents: A systematic review of randomized clinical trials
Cunha et al. Essential oils used in dermocosmetics: Review about its biological activities
Purohit et al. Evaluation of wound healing activity of ethanolic extract of Azadirachta Indica leaves in male albino rats
DE202010011556U1 (en) Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics
DE202007003020U1 (en) Preparation, useful e.g. in disinfecting agent and wound therapy, comprises fundamental oregano oil, Salvia triloba, coriander oil, geranium oil, cinnamon oil and/or lemon grass oil
DE202007015735U1 (en) Preparations as pharmaceuticals, disinfectants, care and hygiene preparations or wound therapeutics
DE202008009382U1 (en) Preparations as pharmaceuticals, disinfectants, skin care and hygiene preparations or wound therapeutics
CN111067866A (en) Wash-free ethanol hand disinfection spray
US20120208877A1 (en) Skin treatment in antiseptic thin film form with silver
Fratini et al. Evaluation of the in vitro antibacterial activity of some essential oils and their blends against Staphylococcus spp. isolated from episodes of sheep mastitis
CN104488993A (en) Disinfectant
Nidhi et al. Role of Essential oils of medicinal plants (Eucalyptus globulus, Thuja occidentalis, Rosmarinus officinalis, Lavandula officinalis) to treat broad spectrum bacterial and fungal pathogens and as antioxidants in food and Health
Diaz et al. Herbal dentifrices for children
DE202007000181U1 (en) Preparation, useful as disinfectant, pharmaceutical-, caring-, hygienic- agent and in wound therapy, comprises two or three combinations of carvacrol, shea butter and silicic acid
CN103550120A (en) Herbal disinfectant
RU2788358C2 (en) Biologically active quadrocomplex for regulation of skin microbiota biodiversity
Wongsariya et al. Evaluation of Thai spice essential oils and their active compounds for anti-cariogenic activity and mechanism of action
Afdilla Minimum Inhibitory Concentration of Aloe Vera And Citrus Limon (L) Burm Extract. F As Antibacterial In Streptococcus Sp, Konsentrasi Hambat Minimum Aloe Vera Dan Citrus Limon (L) Burm Extract. F Sebagai Antibakteri Pada Streptococcus Sp
Choubey et al. In-vitro screening of antibacterial potential of essential oil of lemongrass (Cymbopogon citratus)
Barati et al. In vitro study on the composition and antibacterial effects of aqueous and methanol extracts of on some of food-borne pathogens

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R207 Utility model specification

Effective date: 20101125

R156 Lapse of ip right after 3 years

Effective date: 20140301